Use when packaging AAAI code, data, multimedia appendices, technical appendices, reproducibility evidence, and post-acceptance artifact releases without violating double-blind or immutable-supplement rules.
中文简介正在准备中。当前显示原文说明。
Use when positioning an AISTATS submission against AI, machine-learning, statistics, and uncertainty literature, including arXiv preprints, workshop versions, concurrent submissions, prior conference versions, PMLR archival status, and the two-community citation coverage that AISTATS reviewers expect.
中文简介正在准备中。当前显示原文说明。
实测评分 未实测
查看安装方法安装前可以查看交给 AI 代理的指令内容。
Use this to audit novelty and eligibility. Reopen the current CFP for dual-submission, anonymity, and prior-publication rules before advising authors.
| Literature lane | Typical sources | What AISTATS reviewers check |
|---|---|---|
| ML conferences | NeurIPS, ICML, ICLR, UAI, COLT, prior AISTATS volumes in PMLR | Whether the nearest ML method is compared or explicitly distinguished |
| Statistics journals | Annals of Statistics, JMLR, JASA, Biometrika, EJS | Whether classical estimators and known rates are acknowledged |
| Applied statistical fields | Econometrics, biostatistics, epidemiology | Whether identification and inference assumptions follow standard usage |
A bibliography citing only ML venues tells a statistician reviewer that known statistical results may be getting rediscovered — a recognizable AISTATS reject pattern that no amount of benchmark strength repairs.
Imagine the paper proposes a variance-reduced off-policy evaluation estimator with an asymptotic normality result. Its nearest neighbors: a NeurIPS estimator with no inference guarantee, a JASA semiparametric efficiency bound, and a prior AISTATS paper with a slower rate. The novelty sentence should name all three contrasts — inference where the ML line had none, computational tractability where the statistics line stayed abstract, and a sharper rate than the direct predecessor.
[Eligibility] clear / needs declaration / risky
[Closest literatures] <ML/statistics/application>
[Nearest 3 works] <work -> distinction>
[Archival-overlap risk] <none/issues>
[Novelty sentence] <AISTATS-ready contribution contrast>
还没有评价。欢迎分享你的使用感受。
无需登录即可发表。欢迎分享使用感受、提问,或说明在哪些环境下无法运行。
还没有评论。来写第一条吧。
Use when packaging AAAI code, data, multimedia appendices, technical appendices, reproducibility evidence, and post-acceptance artifact releases without violating double-blind or immutable-supplement rules.
中文简介正在准备中。当前显示原文说明。
Use when drafting an AAAI author response (rebuttal) under the single short character-limited author-feedback window, the no-URL rule, no-new-results guidance, AI-generated-review handling, and the AAAI two-phase review process where Phase-2 papers receive one feedback round before SPC/AC discussion.
中文简介正在准备中。当前显示原文说明。
Use when preparing an accepted AAAI paper for camera-ready source submission to AAAI Press, including proceedings page limits, two-column template compliance, copyright transfer, purchased extra technical pages, deanonymization, registration, oral or poster presentation, and final public artifact release.
中文简介正在准备中。当前显示原文说明。
Use when designing or auditing AAAI experiments for the broad-AI program committee, including baselines, ablations, statistical significance, robustness, human evaluation, AI-for-Social-Impact and alignment/safety evidence, compute and cost reporting, and reproducibility-checklist alignment for Phase-1 survival.
中文简介正在准备中。当前显示原文说明。
Use when positioning an AAAI paper's novelty against archival work, contemporaneous arXiv or workshop papers, and AAAI/IJCAI/NeurIPS/ICML/ICLR neighbors across the broad AI scope, while staying inside AAAI's dual-submission and AI-as-source policy constraints and writing a related-work section legible to non-specialist reviewers.
中文简介正在准备中。当前显示原文说明。
Use when strengthening an AAAI paper's reproducibility checklist (placed after references), experimental traceability, seed and hyperparameter reporting, compute and cost disclosure, dataset access and licensing, code/data ZIP readiness, and the claim-to-evidence map that Phase-1 reviewers use to judge rigor across AAAI's broad AI scope.
中文简介正在准备中。当前显示原文说明。